- In June 2024, The EVERY Company partnered with Canada’s Landish Foods to launch FERMY, a new line of ready-to-mix protein powders designed for beverages such as coffee and matcha. These products feature egg white protein produced via precision fermentation, offering a clean-tasting, animal-free alternative that delivers 8 grams of highly digestible protein per serving. The lineup includes Protein Coffee Enhancer and Protein Matcha Latte, both fortified with functional ingredients such as MCT oil and lion’s mane mushroom. This collaboration reflects a growing shift toward sustainable, functional protein solutions that cater to wellness-conscious consumers and broader applications, including pharmaceuticals
- In March 2023, Israeli biotech startup PoLoPo raised USD 1.75 million in pre-seed funding to advance its molecular farming platform, SuperAA, which produces egg white protein (ovalbumin) in potato plants. This innovative approach uses potatoes as biofactories to generate functional, animal-free proteins identical in structure and nutritional value to conventional egg proteins. The funding—led by FoodLabs and supported by CPT Capital, Siddhi Capital, and others—will accelerate R&D and support the development of protein-rich potato tubers and ovalbumin functional samples. PoLoPo’s technology holds promise for applications in food, nutrition, and pharmaceuticals, while reducing reliance on animal agriculture
- In December 2023, EVERY (formerly Clara Foods) launched its flagship innovation, EVERY Egg—the world’s first liquid egg made without hens, crafted through precision fermentation using yeast. This breakthrough product replicates the taste, texture, and culinary versatility of conventional eggs while eliminating the need for animal agriculture. Developed over nine years, EVERY Egg debuted at the Michelin-starred Eleven Madison Park in New York City, showcasing its appeal to top chefs and food innovators. Beyond culinary applications, this advancement holds promise for pharmaceutical and industrial uses by offering a scalable, consistent, and animal-free source of egg protein
- In November 2022, Nepra Foods Inc. began commercial production and in-plant trials of its Essential brand Egg White Replacement Powder (EPB-ER1)—a proprietary, plant-based alternative to traditional egg white powder. Designed specifically for wholesale bakeries, EPB-ER1 replicates the structural and functional properties of egg whites, making it especially valuable for gluten-free baking, where egg whites often serve as a stabilizer. Unsuch as many starch-based substitutes, this protein-rich solution offers reliable performance in products such as meringues and breads. As demand grows for non-animal-derived proteins, innovations such as EPB-ER1 may also influence pharmaceutical and nutraceutical applications seeking sustainable protein sources
- In February 2021, Blonyx launched the UK's first Egg White Protein Isolate product. This product, designed for athletes and available in a chocolate milk flavor, uses a novel filtering technology to remove sulfur and some sugars from egg whites. While a sports nutrition product, such technological advancements in isolating and refining egg proteins can have implications for developing purer egg protein components for pharmaceutical use
